Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3
World
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Group",
"id" : "189713",
"meta" : {
"versionId" : "3",
"lastUpdated" : "2026-08-05T07:33:36.353Z"
},
"language" : "en",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Group 189713</b></p><a name=\"189713\"> </a><a name=\"hc189713\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 3; Last updated: 2026-08-05 07:33:36+0000</p></div><p><b>ArtifactPublicationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}\">Active</span></p><p><b>Artifact Author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><p><b>CiteAs</b>: </p><div><p>NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json.</p>\n</div><p><b>url</b>: <a href=\"https://fevir.net/resources/Group/189713\">https://fevir.net/resources/Group/189713</a></p><p><b>identifier</b>: FEvIR Object Identifier/189713, FEvIR Linking Identifier/NCT04401202 Eligibility Criteria</p><p><b>name</b>: NCT04401202_Eligibility_Criteria</p><p><b>title</b>: NCT04401202 Eligibility Criteria</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Inclusion Criteria:</p>\n<ul>\n<li>Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia</li>\n<li>Adult (18 Years and above)</li>\n<li>Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).</li>\n<li>Understands and agrees to comply with planned study procedures.</li>\n<li>Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.\nExclusion Criteria:</li>\n<li>Patients with pneumonia or severe illness requiring admission to ICU.</li>\n<li>Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis</li>\n<li>Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).</li>\n<li>Pregnancy or breast feeding.</li>\n<li>Anticipated transfer to another hospital which is not a study site within 72 hours.</li>\n<li>Allergy to any study medication.</li>\n</ul>\n</div><p><b>copyright</b>: </p><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>\n</div><p><b>membership</b>: Conceptual</p><p><b>combinationMethod</b>: All of</p><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Adult (18 Years and above)</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Adult (18 Years and above)</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Understands and agrees to comply with planned study procedures.</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Understands and agrees to comply with planned study procedures.</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.</span></p><p><b>exclude</b>: false</p><p><b>description</b>: </p><div><p>Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Patients with pneumonia or severe illness requiring admission to ICU.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Patients with pneumonia or severe illness requiring admission to ICU.</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal).</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Pregnancy or breast feeding.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Pregnancy or breast feeding.</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Anticipated transfer to another hospital which is not a study site within 72 hours.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Anticipated transfer to another hospital which is not a study site within 72 hours.</p>\n</div></blockquote><blockquote><p><b>characteristic</b></p><p><b>code</b>: <span title=\"Codes:\">Defined by CodeableConcept</span></p><p><b>value</b>: <span title=\"Codes:\">Allergy to any study medication.</span></p><p><b>exclude</b>: true</p><p><b>description</b>: </p><div><p>Allergy to any study medication.</p>\n</div></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code" : "active",
"display" : "Active"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
}
},
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
"valueMarkdown" : "NCT04401202 Eligibility Criteria [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 189713. Revised 2026-08-05. Available at: https://fevir.net/resources/Group/189713. Computable resource at: https://fevir.net/resources/Group/189713#json."
}
],
"url" : "https://fevir.net/resources/Group/189713",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "189713",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
{
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT04401202 Eligibility Criteria",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"name" : "NCT04401202_Eligibility_Criteria",
"title" : "NCT04401202 Eligibility Criteria",
"status" : "active",
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"description" : "Inclusion Criteria:\n* Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia\n* Adult (18 Years and above)\n* Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).\n* Understands and agrees to comply with planned study procedures.\n* Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH.\nExclusion Criteria:\n* Patients with pneumonia or severe illness requiring admission to ICU.\n* Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis\n* Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal).\n* Pregnancy or breast feeding.\n* Anticipated transfer to another hospital which is not a study site within 72 hours.\n* Allergy to any study medication.",
"copyright" : "Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).",
"membership" : "conceptual",
"combinationMethod" : "all-of",
"characteristic" : [
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"
},
"exclude" : false,
"description" : "Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia"
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Adult (18 Years and above)"
},
"exclude" : false,
"description" : "Adult (18 Years and above)"
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."
},
"exclude" : false,
"description" : "Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative)."
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Understands and agrees to comply with planned study procedures."
},
"exclude" : false,
"description" : "Understands and agrees to comply with planned study procedures."
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."
},
"exclude" : false,
"description" : "Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH."
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Patients with pneumonia or severe illness requiring admission to ICU."
},
"exclude" : true,
"description" : "Patients with pneumonia or severe illness requiring admission to ICU."
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis"
},
"exclude" : true,
"description" : "Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) \\< 30) or end stage renal disease requiring dialysis"
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal)."
},
"exclude" : true,
"description" : "Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) \\> 5 times the upper limit of normal)."
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Pregnancy or breast feeding."
},
"exclude" : true,
"description" : "Pregnancy or breast feeding."
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Anticipated transfer to another hospital which is not a study site within 72 hours."
},
"exclude" : true,
"description" : "Anticipated transfer to another hospital which is not a study site within 72 hours."
},
{
"code" : {
"text" : "Defined by CodeableConcept"
},
"valueCodeableConcept" : {
"text" : "Allergy to any study medication."
},
"exclude" : true,
"description" : "Allergy to any study medication."
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-ballot5.
Generated
2026-08-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change